BHC Bausch Health Companies Inc

Bausch Health has completed a set of financing transactions to extend its debt maturities and reinforce its capital structure. This includes exchange offers for new 10.00% Senior Secured Notes due 2032 and a Second Supplemental Indenture with The Bank of New York Mellon, under which the new notes are secured by first-priority liens, expanding the pledge of Bausch + Lomb shares to approximately 60%. These agreements aim to strengthen the company's financial structure.

Zacks Research has reduced its Q4 2025 EPS estimate for Bausch Health (TSE:BHC) to $1.63 and forecasts full-year 2026 and 2027 EPS of $5.37 and $5.30 respectively, which is below the current consensus. Recent analyst upgrades from Barclays and Raymond James have moved the stock to a "Hold" rating, which is also the average analyst rating according to MarketBeat. BHC shares opened at C$9.84 with a market capitalization of C$3.65 billion.

Bausch Health Companies Inc. announced the final results and expiration of its exchange offers for outstanding 4.875% and 11.00% Senior Secured Notes due 2028. The offers, which expired on December 23, 2025, involved tendering existing notes for newly issued 10.00% Senior Secured Notes due 2032. Approximately $2.7 billion in principal amount of existing notes were tendered, leading to the issuance of about $1.6 billion in new notes on the anticipated settlement date of December 26, 2025.

Bausch Health Companies Inc. has finalized an $1.6 billion debt exchange offer, issuing new senior secured notes for existing ones. This move aims to manage its substantial debt load, with the company accepting approximately $1.68 billion of existing notes in exchange. The settlement is expected on December 26, 2025, as Bausch Health continues efforts to improve its financial health.

Bausch Health Companies Inc. announced the final results and expiration of exchange offers for its 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028. The offers, which expired on December 23, 2025, involved tendering existing notes for up to $1.6 billion aggregate principal amount of 10.00% Senior Secured Notes due 2032. Approximately $1.6 billion principal amount of New Notes are expected to be issued on the settlement date, December 26, 2025.

Bausch Health Cos Inc. (NYSE:BHC) saw its shares increase by 4.9% during trading, closing at $7.3350. Analysts have issued varied ratings, with a consensus "Hold" and a price target of $8.67. Several hedge funds have recently adjusted their positions in the company, which operates in ophthalmology and diversified pharmaceutical brands.